Podcasts about Osmosis

“When I was in medical school, no one had even heard of mitochondrial disease. Today, every student who graduates here knows what it is and has seen a patient with it,” says Dr. Mary Kay Koenig, director of the Center for the Treatment of Pediatric Neurodegenerative Disease at UTHealth Houston McGovern Medical School. That remarkable change in awareness has been accompanied by advances in genetic sequencing, the development of clinical guidelines, and the emergence of potential treatments in some forms of mitochondrial disease. In fact, Dr. Koenig's multidisciplinary team at UTHealth's Mitochondrial Center of Excellence has been a key player in clinical trials that may yield the first FDA-approved treatments for it. As you'll learn in this Year of the Zebra conversation with host Michael Carrese, her work in neurodegenerative diseases also includes tuberous sclerosis, where advanced therapies have replaced the need for repeated surgeries, and Leigh Syndrome, which has seen improvements in diagnoses and supportive therapies leading to better quality of life for patients.  Tune in as Dr. Koenig reflects on an era of progress in the space, the rewards of balancing research, teaching and patient care, and the need for more clinicians to center listening, humility and honesty in their approach to caring for rare disease patients and their  families.Mentioned in this episode:Mitochondrial Center of ExcellenceCenter for the Treatment of Pediatric Neurodegenerative Disease If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Thank you for joining us for our 2nd Cabral HouseCall of the weekend! I'm looking forward to sharing with you some of our community's questions that have come in over the past few weeks…   Anonymous: Hi Dr. Cabral I seem to be having very slow motility and lots of undigested food. I might eat 1 meal and stay full/not hungry till the next day. When I do pass the food, so much of it is loose and undigested. I also have what feels like an air bubble that gets stuck in my throat whenever I swallow a pill. It makes it feel as though the pill gets stuck in my throat, but its a feeling that goes down and comes up with drinking of water. Im currently on mag07 and motility activators (combo of artichoke and ginger root) but I still find myself in these situations with much upper stomach pain, bloating and belching. A genesis labs stool test came back fine from the Dr., so not sure I will need a repeat? Ive only been told I have functional dyspepsia and mild gastritis, but thats it. Any advice?                          Jeff: Thank you for all you share. Being married to an IHP2 I'm very blessed with her help with my personal health journey, in addition to "Learning by Osmosis", while she listens and re-listens to every one of your 3000+ podcasts! We just listened to one of your Podcasts recommending using a bamboo cutting board instead of wood and especially plastic. What do you think of the titanium cutting boards that infomercials are pushing now?                                     Darcey: hi Dr. Cabral thank you for everything you've done for us on this health journey. I have a question about the Genesis holistic health, Genesis wild yam cream, a natural and herbal weight to help to restore hormone balance. Do you think that this actually works or do you think it's just a gimmick? it has castor oil, almond oil, grapeseed oil, wild, yam, red clover, chase tree berry, milk thistle, oat straw and cramp bark. You just rubbed too small size amounts morning and night and it's supposed to help rebalance progesterone and estrogen.                                                                                                    Bernice: Hi Dr. Cabral, I absolutely love your podcast and listen to it every day! Thank you for all the great information. I also love your supplements and take the omegas and multivitamins. I am 75 years old and over the last few years have noticed that my skin has become very thin-to the point when I bump into something accidentally, I get these big blotchy red marks. It takes about a week to go away. Is there anything at all that I can do to "thicken" my skin or to prevent these unsightly marks? Thanks so much! Bernice                                                                                                                             Richard: Hello Dr. Cabral, hope you are having a great day! In short, I have had Hashimotos for years and cant seem to get out of this hypothyroid state. I've worked with your amazing team since 2021 and have done every lab and protocol several times. I just finished the CBO & finisher for the 2nd time & now doing my quarterly detox. I also continue to do the heavy metal & parasite protocols annually. I have thyroid tissue destruction as shown by an ultrasound and have narrowed the issue to be this. My EHC recommended the thyroid gland by Vinco. I have tried this several times in the past but it made my insomnia worse & I felt overmedicated. I tried it again after using adrenal energy for several months but still no luck. Can you please provide some info on thyroid glands, the brands you  recommend and how to use them? A podcast dedicated to this would be amazing. I know you can't link products but just talking about them would be very helpful. I could be wrong but it seems like thyroid tissue destruction is rare so its hard to find this kind of info on glandulars. I just ordered the stress,mood & metabolism test to see my adrenal function and I will definitely try the Vinco again after my detox in about a week but I would love your opinion so I have something to fall back on just in case I can't tolerate the glandular. Thanks so much for all that you do!     Thank you for tuning into this weekend's Cabral HouseCalls and be sure to check back tomorrow for our Mindset & Motivation Monday show to get your week started off right! - - - Show Notes and Resources: StephenCabral.com/3544 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

“Giving learners options gives them a better learning experience. It's more holistic and more comprehensive,” says Sean Moloney, CEO and founder of EmbodyXR, an extended reality platform focused on the use of immersive technologies in medical education. In this eye-opening Raise the Line conversation, Moloney explains how AI-powered extended reality (XR) --which integrates augmented, virtual, and simulation-based environments -- allows learners to interact with patients, explore multiple diagnostic choices, and experience varied outcomes based on their decisions. The result, he notes, is not only stronger engagement in learning, but a measurable improvement in understanding. Despite these gains, Moloney is quick to point out that he sees these technologies as complements to traditional training, not substitutes for it. “We'll never replace in-person teaching,” he says, “but we can make learners even better.” Beyond training future clinicians, the EmbodyXR platform is also offering new modes of patient and caregiver education, such as augmented reality guidance for using medical devices at home. Join host Lindsey Smith as she explores how EmbodyXR achieves and maintains clinical accuracy, the connectivity it offers between headsets, personal computers and mobile devices, and other capabilities that are shaping the future of how healthcare professionals and patients will learn. Mentioned in this episode:EmbodyXR If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Why has America struggled so much to effectively manage the opioid use crisis? One of the answers, as you'll learn in this eye-opening episode of Raise the Line, is rooted in laws and attitudes from the early 20th century that removed addiction from the realm of medicine and defined it as a moral failing.  “The federal Harrison Act of 1914 forbade any physician from prescribing opioids to people with addiction, so it became more the purview of law enforcement or behavioral health or religion,” says Dr. Melody Glenn, who regularly confronts the consequences of this history during shifts in the emergency department at Banner-University Medical Center in Tucson, Arizona. And as Glenn explains to host Caleb Furnas, the resulting stigma associated with addiction has extended to the treatments for it as well, especially methadone, despite its effectiveness. Drawing on her dual expertise in emergency and addiction medicine, Glenn dispels misconceptions that medication-assisted treatment merely replaces one addiction with another, and emphasizes that harm reduction is critical to saving lives. Her desire to break prevailing stigmas led her to discover the story of Dr. Marie Nyswander, who pioneered methadone maintenance therapy in the 1960s and is featured in Dr. Glenn's new book, Mother of Methadone: A Doctor's Quest, a Forgotten History, and a Modern-Day Crisis. You'll leave this instructive interview understanding the roots of our flawed approach to addiction treatment, meeting an overlooked pioneer in the field, and admiring a devoted and compassionate physician who is following in her footsteps.  Mentioned in this episode:Banner-University Medical CenterMother of Methadone book If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Critiques de jeux de société récemment sortis : Cookie Party, Miams, Top Ten Aventures, Fifty, Moustache et Osmosis.

“We don't view a person with chronic pain as someone who has a chronic illness and the effect of that is we can't follow patients continuously over prolonged periods of time,” says Dr. Jacob Hascalovici, a neurologist and pain specialist based in New York City.  In co-founding Bliss Health, Dr. Jacob, as he is known, has set out to create a continuous care model for chronic pain treatment that matches the approach taken for patients with diabetes or high blood pressure. The Bliss Health formula includes an initial meeting with a physician that produces a care plan; remote therapeutic monitoring on an ongoing basis; and a monthly meeting with a nurse to review data and determine next steps, including additional appointments with physicians as needed.  All of this occurs via a digital platform which provides a welcome option for patients with mobility issues and can fill gaps in access to specialists, especially in rural areas. Dr. Jacob is also hoping to make chronic pain patents feel respected, which is not always the case in their encounters with the healthcare system. “Because pain is not something that can be seen or measured, oftentimes patients feel marginalized, dismissed and disempowered by providers.” Join Raise the Line host Lindsey Smith for a valuable conversation that also touches on policy changes that could strengthen telemedicine, and has details on the first non-opioid based pain medication to receive FDA approval in over 20 years.Mentioned in this episode:Bliss Health If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In recent months, public health advocates in the United States have raised concerns about proposed changes to vaccine policy, cuts to food assistance programs, rollbacks of environmental protections and reductions in public health staffing. Chief among them has been Dr. Georges Benjamin who, as executive director of the American Public Health Association (APHA) since 2002, has led national efforts to create a healthier America. Raise the Line host Lindsey Smith recently sat down with Dr. Benjamin to understand more about the current state of public health and explore the path forward, and learned that a top priority for APHA is battling the misinformation that Dr. Benjamin believes is fueling support for many of these changes. “The challenge we have right now is that as a society, we've gone into our little corners and live in our own ecosystems. More people are getting their information from a single source and they're not validating that information to make sure that it's true.” Tune into this thoughtful and timely conversation to hear Dr. Benjamin's advice for curbing the spread of misinformation, how APHA is trying to help people understand the value of public health initiatives, and what the U.S. can learn from other countries about improving public health. Mentioned in this episode:American Public Health Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Did you know you can hold a podcast in your off hand? Welcome to the 200th and (kind of) final episode of NOCLIP! With it being both the 200th episode and our tenth anniversary, we figured now would be as good a time as any to finally play Minecraft, one of the most popular and the best selling game of all time, which neither of us had actually played before. Minecraft popularized the previously niche genre of survival games, captivated a huge number of people, and to some degree altered the landscape of online content creation, all while being a procedurally generated game full of blocks created predominately by one guy. Reputation of that one guy aside, it's impressive what this once small game accomplished and the culture it developed. The simplicity of its design allows for more complexity in its systems, with hundreds (probably? Thousands maybe?) of items to craft and a huge world to plumb for resources. The game is also very self-directed, allowing for a lot of player creativity if it does leave you a little directionless at times. The world is equal parts hostile and enticing due to unforgiving enemy spawns and procedural generation, so it is up to the player to determine where and how far they want to go given their current gear and needs. We're going to be talking about the ubiquity of Minecraft in modern culture, the ups and downs of the open nature of the game, and how Minecraft is about two inputs away from a dissociative experience. Thank you for listening this week and for the last, shockingly, ten years. Minecraft is probably the biggest milestone type game we haven't covered yet, and for those of you who have been playing this game for a decade or more, we probably only embarrassingly scratched the surface, so be sure to let us know in the comments or over on our Discord. We have a lot of changes coming soon, the biggest of which is that we are changing the name of the podcast (same great taste though, we aren't changing the format or the contents), so keep an eye on things and don't be shocked when elements of our branding change. Additionally, to celebrate both occasions, we have released a list of my top 100 games of all time, something I've personally wanted to do since I was a kid, so give that a read here (splattershot.pro/top100) if you're interested! Next time, and for the first episode of Describing the Skybox, we're going to be talking about Mouthwashing to kick off the Halloween season! We hope you'll join us then.

“Probably the most exciting thing I've seen in gene therapy over the last ten years is we now have a lot of tools for selective delivery, which will hopefully make treatments more safe and a lot more successful,” says Dr. Jessica Duis, a geneticist and pediatrician focused on the management of individuals with complex, rare disorders. Dr. Duis, who has worked on several gene therapies that are now approved or progressing through the accelerated approval pathway, is currently VP of Clinical Development at GondolaBio, a clinical-stage biopharmaceutical company focused on developing therapeutics for genetic diseases. As you'll learn in this Year of the Zebra episode with host Lindsey Smith, Dr. Duis is encouraged by other recent advances in genetic technology as well, and thinks momentum will grow as breakthrough treatments emerge. “I think we're hopefully going to continue to see companies that are working in rare disease be more successful and really drive how regulators think about making decisions in terms of bringing treatments to patients. I think we're at the tip of the iceberg in terms of the future of truly transformational therapies.”  This wide ranging conversation also explores Dr. Duis' team approach to patient care, her work on clinical endpoints, the importance of patient communities, and her book series, Rare Siblings Stories.Mentioned in this episode:GondolaBioRareDiseaseDocElsevier Healthcare Hub on Rare DiseasesRare Sibling Stories If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

With nearly one in ten newborns in the US requiring care in a Neonatal Intensive Care Unit, the importance of NICUs has never been more clear. On today's episode of Raise the Line, we're shining a light on the extraordinary world of NICUs with Lindsay Howard, a veteran nurse with over 17 years of experience caring for premature and critically ill infants. She currently works in a Level IV NICU at Children's Memorial Hermann Hospital in Houston, one of the most advanced neonatal units in the country. “We call ourselves ‘the ER of the neonate world' because we're never full. We have to make space no matter what comes in off the street, and at the biggest medical center in the world, we see all the things,” she explains. In this enlightening conversation with host Lindsey Smith, Howard describes how advances in medicine have made it possible to provide more types of care for younger and smaller babies, creating a need for NICU nurses to develop subspecialties. In her case, Howard is on a dedicated team that handles the placement and maintenance of all central line IVs, and has earned certifications in neonatal and pediatric chemotherapy and biotherapies. “We see babies that we may not have seen before being born with cancerous tumors who need chemotherapy to try and eliminate it, or just give them more time with their family.” This is a revealing look inside the workings of a top tier NICU where you'll learn about approaches to care that support healthy neurodevelopment, how clinical staff handle the emotional challenges of the job, and how her own experience as a mother with twins needing NICU care impacted her work.  Mentioned in this episode:Children's Memorial Hermann Hospital If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Après le retour de Vichy, les sorties s'accélèrent et cette semaine, 3 sorties majeures : Tag Team, Miams et Osmosis ! Combien de jeux est-ce que vous attendiez parmi ces 3 là ?Préparez vous, parce que la semaine prochaine sera très clairement LA plus grosse semaine de l'année !______________________________________

“When you think about where we were as a country before Medicare and Medicaid were created and where we are now, it's an incredible story,” says Chiquita Brooks-LaSure, who until earlier this year was the administrator for the Centers for Medicare and Medicaid Services (CMS). In a recent essay for The Century Foundation, where she is now a senior fellow, Brooks-LaSure used the 60th anniversary of enactment of those foundational insurance programs to help put their impact on individual Americans, the healthcare system and society at large in perspective. One prominent example is the desegregation of hospitals, which was achieved in part by withholding reimbursements for care unless facilities served Blacks as well as whites. Another is making it possible for more people with disabilities to live at home instead of in institutional settings. But as you'll hear in this probing Raise the Line conversation with host Lindsey Smith, Brooks-LaSure worries that many gains in coverage and other progress made over the years through Medicare, Medicaid and the Child Health Insurance Program (CHIP) are at risk because of a new federal law that calls for a trillion dollar decrease in spending, resulting in potentially millions of people losing their coverage, cuts to clinical staff and medical services, and the closure of hospitals and clinics, especially in rural areas. “Most rural hospitals in this country are incredibly dependent on both Medicare and Medicaid to keep their doors open and there's an estimate that over 300 hospitals will close as a result of this legislation, so that, I think, is a place of incredible nervousness.” Whether you are a patient, provider, policymaker or health system leader, this is a great opportunity to learn from an expert source about the range of potential impacts that will flow from changes to critically important insurance programs that provide coverage to 40% of adults and nearly 50% of children in the U.S. Mentioned in this episode:The Century FoundationEssay on 60th Anniversary of Medicare & Medicaid If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

THE KING OF SPADES!! Alice In Borderland Full Reaction Watch Along:   / thereelrejects   Visit https://huel.com/rejects to get 15% off your order Alice In Borderland Season 1 Episode 1, 2, & 3 Reaction    • ALICE IN BORDERLAND Season 1, Eps 1, 2, & ...   With Alice In Borderland Season 3 around the corner, it's time for Alice in Borderland Season 2 Episodes 1–3 Reaction, Recap, Commentary, Analysis, Breakdown, & Spoiler Review. Aaron Alexander and Tara Erickson dive deep into the intense start of Season 2, where Arisu (Kento Yamazaki – Kingdom, Orange), Usagi (Tao Tsuchiya – Rurouni Kenshin, The 8-Year Engagement), Kuina (Aya Asahina – Girl Gun Lady), and Tatta (Yutaro Watanabe – Gunjou no Subete) face the terrifying King of Spades, one of the deadliest Face Card challenges yet. Separated survivors like Chishiya (Nijiro Murakami – Kakegurui) and Ann (Ayaka Miyoshi – Dance With Me) must also fight to endure. The shocking “Osmosis” game against Kyuma (Tomohisa Yamashita – Code Blue) raises the stakes with high-risk team combat, brutal strategy, and unexpected twists. Tatta's heartbreaking backstory unfolds, Arisu risks everything to protect Usagi, and we see new layers of trust, betrayal, and survival that set the tone for the season. Packed with shocking violence, emotional beats, and gripping social commentary, these episodes set up the battle between players and Citizens that defines Season 2. With Stranger Things 5 and Severance 2 setting the bar high for modern streaming, Alice in Borderland continues to prove why it's Netflix's crown jewel of Japanese thriller drama. Follow Aaron On Instagram: https://www.instagram.com/therealaaronalexander/?hl=en Follow Tara Erickson: Youtube: https://www.youtube.com/@TaraErickson Instagram:  https://www.instagram.com/taraerickson/ Twitter:  https://twitter.com/thetaraerickson Intense Suspense by Audionautix is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/... Support The Channel By Getting Some REEL REJECTS Apparel! https://www.rejectnationshop.com/ Follow Us On Socials:  Instagram: https://www.instagram.com/reelrejects/  Tik-Tok: https://www.tiktok.com/@reelrejects?lang=en Twitter: https://x.com/reelrejects Facebook: https://www.facebook.com/TheReelRejects/ Music Used In Ad:  Hat the Jazz by Twin Musicom is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Happy Alley by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/... POWERED BY @GFUEL Visit https://gfuel.ly/3wD5Ygo and use code REJECTNATION for 20% off select tubs!! Head Editor: https://www.instagram.com/praperhq/?hl=en Co-Editor: Greg Alba Co-Editor: John Humphrey Music In Video: Airport Lounge - Disco Ultralounge by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Ask Us A QUESTION On CAMEO: https://www.cameo.com/thereelrejects Follow TheReelRejects On FACEBOOK, TWITTER, & INSTAGRAM:  FB:  https://www.facebook.com/TheReelRejects/ INSTAGRAM:  https://www.instagram.com/reelrejects/ TWITTER:  https://twitter.com/thereelrejects Follow GREG ON INSTAGRAM & TWITTER: INSTAGRAM:  https://www.instagram.com/thegregalba/ TWITTER:  https://twitter.com/thegregalba Learn more about your ad choices. Visit megaphone.fm/adchoices

It seems there are news stories every week about the accelerating pace of innovation in gene therapy, but only about 50 therapies have been approved so far by the US Food and Drug Administration. Our guest today, Dr. Bobby Gaspar, leads a UK-based biotech company, Orchard Therapeutics, that developed one of those treatments using gene-modified stem cells in your blood that self-renew, so a single administration can give you potentially a lifelong effect. “Our approach is about correcting those hematopoietic stem cells and allowing them to give rise to cells that can then correct the disease,” explains Dr. Gaspar.  The therapy in focus is lenmeldy, the first approved treatment for metachromatic leukodystrophy, also known as MLD, a devastating inherited disorder that affects roughly 600 children worldwide. But Dr. Gaspar is optimistic that learnings from Orchard's work on MLD could be useful in treating much more common disorders including frontotemporal dementia, Crohn's disease and others. This highly informative conversation with host Lindsey Smith also explores the importance of newborn screening, community collaboration in advancing clinical trials for rare diseases, and a future in which each gene therapy will be used as a tool for specific applications.  “There will be many gene therapies available, some of which will become the standard of care for certain diseases, but it won't be for every disease.”Mentioned in this episode:Orchard Therapeutics If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Have you heard of growth osmosis? This is the belief that you can grow and rise to the extent of those surrounding you, and based upon their level of growth. In this episode, I share my own journey with this, how I've normalised coaches who earn $400,000 cash months and how having those high level conversations has made me RISE!Plus, join my free 31 day coaching experience in October - 31 to Thriving! This will be true growth osmosis in action! Register here.

You are in for a dose of inspiration in this episode of Raise the Line as we introduce you to a rare disease patient who was a leading force in establishing the diagnosis for her own condition, who played a key role in launching the first phase three clinical trials for it, and who is now coordinating research into the disease and related disorders at one of the nation's top hospitals. Rebecca Salky, RN, was first afflicted at the age of four with MOGAD, an autoimmune disorder of the central nervous system that can cause paralysis, vision loss and seizures. In this fascinating conversation with host Lindsey Smith, Rebecca describes her long and challenging journey with MOGAD, her work at the Neuroimmunology Clinic and Research Lab at Massachusetts General Hospital, and the importance of finding a MOGAD community in her early twenties. “There's a sense of power and security when you have others on your side. You're not alone in this journey of the rare disease,” she explains. Be sure to stay tuned to learn about Rebecca's work in patient advocacy, her experience as a nurse, and the three things she thinks are missing in the care of rare disease patients as our Year of the Zebra series continues.Mentioned in this episode:The MOG ProjectNeuroimmunology Clinic & Research Lab at Mass General If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

“You have to love what you do, especially in healthcare, and the earlier you find that, the better. So that's why I love to see HOSA helping young people find what it is that they want to do,” says Dr. David Kelly, a fellow in oculofacial surgery at University of California San Francisco and HOSA's board chair. You can still hear the excitement in Dr. Kelly's voice describing his earliest experiences with HOSA -- a student led organization with 300,000 plus members that prepares future health professionals to become leaders in international health – even though they happened sixteen years ago when he was a sophomore in highschool. Through hundreds of competitive events and hands-on projects, HOSA creates a framework for developing skills in communication, professionalism and leadership starting in middle school. Programs are offered throughout highschool and college as well, which Dr. Kelly took advantage of before becoming an active alumnus and joining the HOSA board as a way of giving back to an organization that has given so much to him. Since taking the reins as board chair last year, one key focus has been preparing to mark HOSA's 50th anniversary in 2026. Dr. Kelly sees the occasion as not only an opportunity to celebrate what HOSA has accomplished, but to ensure it is positioned to continue helping the healthcare industry tackle important challenges in the future. Examples include chronic workforce shortages and improving how clinicians communicate with patients and team members.  Join host Lindsey Smith on this uplifting Raise the Line episode for an optimistic look at the next generation of healthcare leaders.Mentioned in this episode:HOSAHOSA Alumni Registration If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

You’ve layered on dark spot serums and SPF like it’s your full-time job… and yet those spots are still hanging around. Why is pigmentation so stubborn, and what can skincare actually do about it? In this episode of Expert, we break down everything you need to know about treating pigmentation, from sun damage, hormonal changes, PIH, and melasma, to figuring out which type you have. We cover which serums really work, when to consider in-clinic treatments like lasers or peels, and the top ingredients to fade dark spots, including vitamin C, tranexamic acid, azelaic acid, retinoids, and kojic acid. We also discuss why pigmentation can recur, the actual timeframe for results, and share tried-and-tested product recommendations for every budget, including favourites from Dermalogica, Ole Henriksen, Cosmedix, Société, Osmosis, and L’Oréal Paris (all linked below). Plus, in Win, Bin or Recycle, we ask if face cupping is trend or trash, and in Adore Anonymous, we answer: tranexamic acid vs. azelaic acid: Can you actually use them together? Everything Mentioned: L'Occitane Almond Shower Oil 500ml PCA Skin Body Therapy 206.5ml mesoestetic mesoprotech melan 130 pigment control 50ml L’Oreal Paris Bright Reveal Dark Spot Face Serum 30ml Ole Henriksen Glow2OH Dark Spot Toner 190ml Osmosis Perfection Pigment Corrector Dermalogica Powerbright Dark Spot Peel Société Even Out Dark Spot Corrector Cosmedix Simply Brilliant 24/7 Brightening Serum Acne, Rosacea or Pigmentation? You Need to Know About Azelaic Acid Credits: Hosts: Tegan Mac and Sadaf Razi Producer: Jasmine Riley For more beauty insights and exclusive offers, visit adorebeauty.com.au Disclaimer | Privacy Policy Adore Beauty acknowledges the Traditional Owners of the land on which we work and podcast. We pay our respects to Elders past, present and emerging.See omnystudio.com/listener for privacy information.

“We've been able to show that even by 30 days of age, we can predict with some accuracy if a child is going to have a diagnosis of autism,” says Dr. Geraldine Dawson, sharing one of the recent advancements in early diagnosis being aided by artificial intelligence.  Dr. Dawson -- a leading scholar in the field and founding director of the Duke Center for Autism and Brain Development – explains that an AI examination of a child's pattern of visits to medical specialists in its very early life is an objective diagnostic tool that can supplement the current subjective reports from parents which vary in reliability. Another objective diagnostic tool in development uses a smartphone app developed at Duke that takes video of babies watching images and applies AI-aided Computer Vision Analysis to measure for signs of autism. This enlightening Raise the Line conversation with host Lindsey Smith is loaded with the latest understandings about Autism Spectrum Disorder including advancements in early therapeutic interventions, the interplay of genetic and environmental factors, and the role of the mother's health and exposures during pregnancy. You'll learn as well about what Dawson sees as necessary societal shifts in how autism is perceived, the numerous factors contributing to a near tripling of diagnoses over the past two decades, and how early intervention and informed advocacy can make a meaningful difference in the lives of countless families.Mentioned in this episode:Duke Center for Autism and Brain Development If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

"Burnout and trauma are not mental illnesses. They live in your physiology. They live in your biology. They live very specifically in your nervous system,” Dr. Rola Hallam says with a conviction rooted in her own successful journey to overcome the effects of chronic stress she accumulated during many years on the frontlines of humanitarian crises in Syria and other conflict zones. Out of concern for the multitudes of health professionals who, like herself, spend years carrying the weight of their traumatic experiences without seeking help, or who pursue ineffective remedies for relieving it, Dr. Rola -- as she's known – has shifted her focus to being a trauma and burnout coach. Among her offerings is Beyond Burnout, a twelve-week program that includes multimedia content as well as live coaching and teaching about developing nervous system awareness and regulation. “Most wellness initiatives fail because they're not rewiring the nervous system to come out of survival mode and back into what is called the ventral-vagal state, which is our state of social connection and of healing and repair.” She also stresses that healing is not an individual pursuit, especially for providers who work in a relational field, and teaches about the benefits of borrowing from a colleagues' state of calm and offering them the same. Don't miss this insightful and giving conversation with host Lindsey Smith that covers Dr. Rola's wrenching experiences providing care in desperate conditions, the critically important distinction between empathy and compassion, and how empowering frontline workers to heal their trauma can uplift individuals and empower entire communities. Mentioned in this episode:Dr. Rola CoachingBeyond Burnout AssessmentCanDo - Humanitarian Aid If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Let us know your thoughts. Send us a Text Message. Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedInEpisode Title:

“Seeing that you can get through the most difficult times in life, succeed, and then also return to your community and work in service to your community was a lesson that has stuck with me,” says Dr. Uche Blackstock, the Founder and CEO of Advancing Health Equity and our guest on this inspiring episode of Raise the Line with Osmosis from Elsevier. It was a lesson the Harvard-trained physician learned from her own mother – also a Harvard trained physician – who overcame poverty, sexism and racial bias to forge an inspiring path.  In her bestselling book, Legacy: A Black Physician Reckons with Racism in Medicine, Dr. Blackstock weaves her mother's remarkable story with her own and argues for systemic change in a healthcare system riddled with racially-biased practices and policies that impact patient outcomes. As she explains to host Lindsey Smith, Advancing Health Equity's work to drive measurable and sustainable change is focused on embedding equity as a core value in the leadership, strategy, and organizational practice of health systems. “We exist to challenge inequities, empower underrepresented communities, and help build a healthcare system where everyone can thrive.” Don't miss a thought-provoking conversation with a nationally respected voice that also addresses race correction factors that impact the care of Black patients, and the work required of health institutions to build trust in effected communities.Mentioned in this episode:Advancing Health EquityLegacy: A Black Physician Reckons with Racism in Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

You asked, we delivered! Killing Time is back (for a limited time only) and our very own Jared is back to guest host with us. Things got weird pretty fast. We're talking Katy Perry & Justin Trudeau going on a first date, Orlando Bloom punching Justin Bieber, Cheesecake Factory vs P.F. Chang's, an alien invasion coming in October, and how exactly does an eel get stuck in one's intestine??

“Pandemics are a political choice. We will not be able to prevent every disease outbreak or epidemic but we can prevent an epidemic from becoming a pandemic,” says Dr. Joanne Liu, the former International President of Médecins Sans Frontières/Doctors Without Borders and a professor in the School of Population and Global Health at McGill University. You are in for a lot of that sort of frank and clear-eyed analysis in this episode of Raise the Line from Dr. Liu, whose perspective is rooted in decades of experience providing medical care on the frontlines of major humanitarian and health crises across the globe, as well as wrangling with world leaders to produce more effective responses to those crises and to stop attacks on medical facilities and aid workers in conflict zones. Firsthand accounts from the bedside to the halls of power are captured in her new book Ebola, Bombs and Migrants, which focuses on the most significant issues during her tenure leading MSF from 2013-2019.  The book also contains insights about the geopolitical realities that hamper this work, including lax enforcement of international humanitarian law, and a focus on national security that erodes global solidarity. Join host Lindsey Smith as she interviews this leading voice on our preparedness to meet the needs of those impacted by violent conflict, forced migration, natural disasters, disease outbreaks and other grave challenges. If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

What does it look like when billion-dollar funds put impact at the core of their investment strategy?In this 3-in-1 compilation episode, we revisit conversations with investors managing tens of billions across public fixed income, public equities, private equity, and impact-focused real estate. Each one makes the case that environmental and social outcomes aren't a tradeoff – but a source of lasting value and market-beating returns.Meet the leaders turning billions into measurable impact:Michele Giddens, Co-Founder and CEO of Bridges Fund ManagementBridges was launched in 2002 with £40 million – including just £10 million in catalytic capital. Today, it manages over £2 billion across private equity, impact real estate, and outcomes contracts. From the start, its mission has been to invest in solutions that drive both a more inclusive economy and a more sustainable planet – ideally, both at once. Michele describes their theory of change simply: addressing systemic social and environmental challenges isn't a tradeoff – it's a way to unlock high-performing markets. Whether it's converting inefficient office buildings into low-carbon co-living hubs or financing housing solutions for marginalized youth, Bridges targets overlooked problems with market-driven solutions.Full episodeBen Dear, Founder and CEO of Osmosis Investment ManagementOsmosis was built on a simple but overlooked idea: companies that generate more economic value while using less carbon, water, and waste will outperform. Ben believed resource efficiency wasn't just good for the planet – it could be a consistent, data-driven investment factor.He was right. Today, Osmosis manages over $17 billion in global public equity strategies, all powered by their own proprietary environmental data. They collect and standardize metrics across carbon, water, and waste – giving them a lens on corporate performance that most investors miss.Their low-risk flagship targets just 0.5–1% above benchmark returns – yet still outperforms two-thirds of global equity funds on Morningstar. Their higher-alpha strategies deliver 2–3% annually, while cutting portfolio footprints by up to 70%.Check out the full interview: Part 1Part 2Stephen M. Liberatore, Head of ESG and Impact for Global Fixed Income at NuveenNuveen manages just over $1 trillion globally – and Steve oversees more than $20 billion of that in ESG and impact-focused public fixed income, across 38 distinct funds.While most associate impact with private markets, Steve has built one of the world's largest impact bond strategies by focusing on public debt. His theory of change is rooted in scale: in 2023, public fixed income financed over $800 billion in climate transition – ten times more than private equity and venture combined.Every security in Steve's portfolios must deliver a direct, measurable environmental or social outcome. That means no sustainability-linked bonds with vague KPIs. Instead, the team targets use-of-proceeds instruments that reduce financing costs for projects like clean energy, affordable housing, and ecosystem restoration – while delivering market-rate returns.Full episode—Connect with SRI360°:Sign up for the free weekly email updateVisit the SRI360° PODCASTVisit the SRI360° WEBSITEFollow SRI360° on XFollow SRI360° on FACEBOOK

“As parents dedicated to getting a treatment for our children in their lifetimes, we have turned the rare disease drug development landscape upside down and created a new model,” says Nicole Johnson, co-founder and executive director of the FOXG1 Research Foundation.  That's not an exaggeration, as the foundation is on track to make history as it begins patient clinical trials on a gene replacement therapy next year. The former TV news producer and media executive unexpectedly entered the world of patient advocacy and drug research after her daughter, Josie, was born with FOXG1, a genetic disorder which causes severe seizures and impedes normal movement, speech, and sleep among other problems. Johnson is also making an impact in another important dimension of the rare disease space in her efforts to educate parents, teachers, and students about disability inclusion through her Joyfully Josie book series and “Live Joyfully” education programs. Tune-in to this fascinating Year of the Zebra conversation with host Lindsey Smith to find out how the foundation is aiming to bring a drug to market in less than half the time and at a fraction of the cost than the industry standard, and how this model might impact research on other rare disorders. Mentioned in this episode:FOXG1 Research FoundationJoyfully Josie Book If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Today on Raise the Line, we bring you the unlikely and inspiring story of a woman who was afraid of blood as a child but became an accomplished nurse; who struggled with learning disabilities but became an effective educator; and who, despite lacking business experience or knowledge of graphics, built a successful company that produces visually rich educational materials for nurses and other providers. “I think the theme of my life has been I have struggled with learning, and I didn't want other people to struggle,” says Jennifer Zahourek, RN, the founder and CEO of RekMed which has developed a sequential, interactive learning system that includes illustrated planners, books, and videos used by millions of students and providers. The initial focus was to provide nurses with everything they needed to know from “the basics to the bedside” but RekMed now offers content for medics, respiratory therapists, medical assistants, and veterinarians as well. Driven by her belief in the power of visual learning and her “just freakin' do it” attitude, Jennifer overcame her fear of launching a business and quickly realized just how well nursing had prepared her for the hard work and unpredictability of entrepreneurship. “Nursing teaches you how to just be resilient, to pivot, to delegate, to work on a team and to handle high stress. I think nurses could literally be some of the best entrepreneurs on the planet,” she tells host Lindsey Smith. Tune in to this lively and valuable conversation as Jennifer shares lessons from bootstrapping a publishing company, insights on the evolving landscape of healthcare education, and advice on embracing change in nursing, especially with the expanding role of AI. Mentioned in this episode:RekMed If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

“Very often, doctors try to suppress what they feel or don't even have the vocabulary to describe their emotions,” says Professor Alicja Galazka of the University of Silesia, an observation based on decades of work with physicians to enhance their emotional intelligence and resilience. Galazka, a psychotherapist, psychologist, lecturer and coach, believes this deficit is rooted in part in a lack of instruction in the internal and external psychological dimensions of being a medical provider. “There is not enough space created in medical school for teaching and training students about how to deal with their own stress and all of the skills connected to building relationships with patients,” she tells host Michael Carrese. Those same skills are also critical to working effectively as a member of a care team, which is an increasingly common arrangement in hospitals and clinics. Galazka employs simulations, dramatic role-playing, mindfulness, Acceptance and Commitment Therapy and other methods in her work with an eye on increasing the emotional agility and sensitivity of her trainees and clients. Tune in to this thoughtful episode of Raise the Line to hear Galazka's ideas on how to reshape medical training, why she is a proponent of narrative medicine, and the merits of embedding psychologists on care teams as a resource for both patients and providers. Mentioned in this episode:University of SilesiaInternational Association of Coaching Institutes If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

What if the solution your skin needs isn't in a bottle—but in a plant?This week on the She Built It® Podcast, I'm joined by Tammy Demos, founder of KLEOS+KLEA, whose journey to heal her own skin led her to challenge the entire skincare industry. From co-founding two beauty brands to starting over with nothing but aloe vera and a vision, Tammy shares how nature, resilience, and a bathroom apothecary became the foundation of a brand built on truth.We talk about what's really missing in “clean” skincare, how nutrient-stacking works, and why going fully natural was the boldest (and smartest) move she's ever made. Her story is one of radical simplicity, scientific curiosity, and a mission to reconnect us with the power of plants.Whether you're passionate about skincare, love hearing stories of reinvention, or just need a reminder to trust your instincts—this one's for you.

the process of gradual or unconscious assimilation of knowledge and or ideas

Cosmos has contributed a LOT to the Web3 space, and is going through a significant revival. It's time to dig deeper into this OG Blockchain ecosystem that has contributed so much to interoperability and cross-chain apps.If you're in Web3, you've probably heard of Cosmos. You've probably heard of Osmosis, and if you're vaguely technical you've probably heard of IBC (Inter-Blockchain Communication protocol). But that's not where the story ends.The Cosmos ecosystem is smart, vibrant and determined. However, for many reasons (which we'll cover on this show) Cosmos hasn't received the recognition or escape velocity it perhaps deserves.On this LinkedIn Live, we meet Crypto Cito, one of the strongest and longest-serving advocates for the Cosmos ecosystem, so who better to give us the story of what was and what will be...In this show we cover:- Cosmos 101 (The tech and why it matters)- Cosmos 201 (The ecosystem and evolution of the community)- Use cases, builders and apps you should know- The roadmap - where next for Cosmos

Ever wondered what it takes for a skincare brand to win a prestigious award? In this episode, we spotlight the Science of Skin awards, where innovation and science-backed formulations reign supreme. The Science of Skin Awards, hosted by Skincare Anarchy LLC, represent the gold standard in skincare innovation. With only ten brands receiving this prestigious recognition each year, the awards celebrate the intersection of cutting-edge technology and pioneering advancements in skin science.These awards are renowned for their rigorous scientific evaluation process, which ensures that winning brands demonstrate a high standard of scientific validity. They're not just presenting novel ideas, but also proving the effectiveness of their products.The Science of Skin Awards serve as a global beacon for consumers. By receiving this award, a brand signals that its over-the-counter products are based on sound science, offer tangible benefits, and can be trusted for their claims. Tune in as we explain our trailblazing awarded brands!CHAPTERS:(0:00) Introduction and What is Science of Skin?(1:17) Neutrogena(2:09) Timeline(5:13) Peace Out(7:56) The Inkey List(9:01) NuFace(10:29) DefenAge(12:42) Cellcosmet(13:43) Osmosis(14:42) Serucell(17:30) Dr. IvyShop all Science of Skin 2025 WinnersPlease fill out this survey to give us feedback on the show!Don't forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf! Hosted on Acast. See acast.com/privacy for more information.

"Older adults have this special clarity about who they are and what they want, which is incredibly inspiring," says Dr. Julia Hiner, explaining, in part, why she loves her work as a geriatrician in Houston, Texas. She also enjoys the challenge of the medical complexity these patients present and the opportunity it creates to see the patient as a whole person. In fact, as you'll hear in this upbeat conversation with Raise the Line host Lindsey Smith, there's almost nothing about geriatrics that Dr. Hiner does not enjoy, which explains her passion for teaching the subject at McGovern Medical School at the University of Texas Health Science Center in Houston and trying to convince more students to pursue it as their specialty.  The need is great, given that there are only 8,000 geriatricians in the US despite a rapidly growing senior population. Tune in to learn why Dr. Hiner thinks clinicians avoid the field and the steps that can be taken to improve the situation, including requiring courses in geriatrics. You'll also learn about the importance of capacity assessments, the troubling, and under-reported, problem of elder mistreatment, ageism among health professionals and much more in this super informative episode. Mentioned in this episode:University of Texas Health Science Center at Houston McGovern Medical School  If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Why Meghan Markle's Podcast Is Going on Hiatus (E! Online) (24:52) Anne Burrell went into ‘cardiac arrest' before tragic death: 911 caller (Page Six) (38:06)Tyler Perry accused of sexual assault in $260M lawsuit filed by ‘The Oval' actor Derek Dixon (Page Six) (44:16)Kylie Jenner's daughter, Stormi, hilariously throws shade at ‘King Kylie' era (Page Six) (57:56) Lindsay Hubbard Reveals Whether She's Returning to Summer House After Becoming a Mom (PEOPLE) (1:06:29)Love Island USA Recap (1:11:50)The Toast with Jackie (@JackieOshry) and Lauren Elizabeth (@laurenelizabeth) Lean InThe Camper and The Counselor by Jackie OshryMerchThe Toast PatreonGirl With No Job by Claudia OshrySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

"It was pretty apparent to me that something was going on with him," says Kristi Levine, describing the realization that, based on her experience as a Montessori teacher, her infant son, Trey, was missing developmental milestones. Unfortunately, Kristi's hunch turned out to be correct and Trey was later diagnosed with a rare genetic mutation called CACNA1A which is impacting his motor skills, balance, coordination and speech. Kristi and her husband, Eric, join host Michael Carrese on this installment in our Year of the Zebraseries to help us understand the disorder and its implications for Trey and their family, which includes Trey's older sister Stella.  “There's a lot of guilt involved in being a parent of a child who has a disability because you never feel like you're doing enough,” shares Eric, even though they both work full time and have becoming experts at juggling work, caregiving, advocating, and volunteering with the CACNA1A Foundation. In this candid interview, Eric and Kristi discuss the challenges of parenting a child with complex medical needs, the importance of community support, the ongoing search for treatment options, and share some advice for clinicians caring for patients and families living with rare disorders. “We just want medical professionals to respect and understand what we're dealing with on a day-to-day basis and to see our kids holistically, and not just try to fix the problem medically. Understand that for us, the biggest thing that we want for our kids is just their quality of life.”Mentioned in this episode:CACNA1A Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

We have a special guest on today's episode whose voice will be familiar to regular listeners. Last year at this time, Dr. Raven Baxter occupied the Raise the Line host chair for a special ten-part series we produced in collaboration with the Cohen Center for Recovery from Complex Chronic Illness (CoRe) at Mount Sinai in New York City, where she serves as the Director of Science Communication. The series explored the latest understandings of post-acute infection syndromes -- such as Chronic Lyme and Long COVID -- with an array of experts from the Center and other researchers and providers. In this episode, we check-in with Dr. Baxter to get an update on the work of the Cohen Center, especially with regard to its mission to educate providers. “We're building programs so that clinicians can earn credit for learning about chronic illnesses that are infection associated, and we've also developed a 200-page provider manual. I really think that we will be able to shift the narrative that currently exists,” Dr. Baxter tells host Michael Carrese. That narrative includes lingering skepticism among providers of some infection-associated illnesses, which Dr. Baxter witnessed herself as a Long COVID patient, an experience that has added meaningful perspective to her work. Dr. Baxter is also working on her own time to advance knowledge and combat misinformation through a robust social media presence as “The Science Maven” and helps other scientists and clinicians to do the same. "If we're not there to fill in that void, other people will fill it for us and the narrative may not be consistent with the truth or facts." This is a great opportunity to learn about the art and science of communications that can reach clinicians and patients alike.Mentioned in this episode:Cohen Center for Recovery from Complex Chronic IllnessThe Science Maven If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

With a new sheriff in town and new roadmap in tow, here's how the ATOM ecosystem is ready to go big. With plans to 100x the current liquidity sloshing across the network, Interchain Labs is gearing up for a big Cosmos resurgence.#blockchaintech #technews #web3news #interchainfm #cryptocurrency #cryptopodcasts #cosmosatom #cosmosnetwork

On this episode of “Raise the Line” we welcome Dr. Sheldon Fields, a trailblazer in the nursing field and the president of the National Black Nurses Association. In a candid conversation, Dr. Fields shares his inspiring journey from the bedside to becoming a prominent figure in nursing, HIV/AIDS prevention and academia and also shares the challenges he faced as a Black man in a predominantly white and female field. "I fell in love with a profession that has not always loved me back," he tells host Kelsey Lafayette. Dr. Fields brings over thirty years of experience as an educator, researcher, clinician, administrator, consultant, health policy specialist, and entrepreneur to his current role at NBNA, and as the inaugural associate dean for equity and inclusion at the College of Nursing at Penn State University, where he also serves as a research professor. Listeners will find Dr. Fields' insights on navigating a career in healthcare particularly valuable, as he stresses the importance of resilience, continuing education, and mentorship. It's a compelling listen for anyone interested in the intersection of health, policy, and social justice.Mentioned in this episode:National Black Nurses Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast